Los puntos clave no están disponibles para este artículo en este momento.
Creating clinical practice guidelines can be a long and expensive process, and guideline writers are always in search of funding. Enter the pharmaceutical industry. Of course, whenever drug companies foot the bill for any type of medical research, the question invariably arises: Will the money bias
Roger Collier (Mon,) studied this question.